SCHEMBL6383337

SCHEMBL6383337

CCCCCCc1c(C(=O)O)c(CC)c(CC)c2c(C(=O)O)cccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 5/20 0.46
PPARA Q07869 4/20 0.46
BID P55957 3/20 0.46
MCL1 Q07820 3/20 0.46
BCL2L1 Q07817 2/20 0.46
BAK1 Q16611 2/20 0.46
PPARG P37231 2/20 0.46
EP300 Q09472 2/20 0.46
KAT5 Q92993 2/20 0.46
SAE1 Q9UBE0 2/20 0.46
KAT2A Q92830 1/20 0.46
KAT2B Q92831 1/20 0.46
F7 P08709 3/20 0.41
F3 P13726 3/20 0.41
PLK1 P53350 3/20 0.41
MMP2 P08253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
ECE1 P42892 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1615392 0.84 BID (0.49) KAT8PPARABIDMCL1BCL2L1
SCHEMBL9329846 0.79 BID (0.40) KAT8PPARABIDMCL1BCL2L1
SCHEMBL29733639 0.78 BID (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL168253 0.78 BID (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL8757448 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL27944035 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL14836221 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL27944047 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL28103139 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1
SCHEMBL27944038 0.77 KAT8 (0.53) KAT8PPARABIDMCL1BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1323412-B1 Light screening composition comprising a dibenzoylmethane type screening agent and an amino substituted 2-hydroxybenzophenone derivative ORÉAL L (FR) 2016-10-19 EP claimed
US-20050019279-A1 Cosmetic or dermatological preparation containing an octadecene dioic acid and a UV filtering substance BEIERSDORF AG 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050019279-A1 Cosmetic or dermatological preparation containing an octadecene dioic acid and a UV filtering substance MC1R, CUTA, DOHH KAT8 358/4885PPARA 187/4885BID 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.